Article Information
vol. 8 no. 3
Published By
Online ISSN
History
- Received March 22, 2022
- Accepted May 26, 2022
- Published online September 26, 2022.
Article Versions
- previous version (June 9, 2022 - 05:05).
- previous version (June 16, 2022 - 07:49).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright ©The authors 2022 This version is distributed under the terms of the Creative Commons Attribution Licence 4.0.
Author Information
- Stephen G. Noorduyn1,2,
- Christina Qian3,
- Karissa M. Johnston3,4,
- Mena Soliman1,
- Manisha Talukdar1,
- Brandie L. Walker5,
- Paul Hernandez6 and
- Erika Penz7
- 1Dept of Medical Affairs, AstraZeneca Canada, Mississauga, Canada
- 2Dept of Health Research Methods, Evidence & Impact, McMaster University, Hamilton, Canada
- 3Broadstreet HEOR, Vancouver, Canada
- 4Memorial University, St John's, Canada
- 5Division of Respirology, Dept of Medicine, University of Calgary, Calgary, Canada
- 6Division of Respirology, Dept of Medicine, Dalhousie University, Halifax, Canada
- 7Division of Respirology, Critical Care and Sleep Medicine, University of Saskatchewan, Saskatoon, Canada
- Corresponding author: Erika Penz (Erika.penz{at}usask.ca)
Funding
AstraZeneca Canada Inc.
Article usage
Altmetrics
Vol 8 Issue 3
Table of Contents
SABA use as an indicator for asthma exacerbation risk: an observational cohort study (SABINA Canada)
